A method of treating seizures, epilepsy or loss of brain function in an individual comprising the steps of preparing a composition composed of an all-D amino acid peptide and a pharmaceutically acceptable carrier.The D peptide has the general structure: A-B-C-D-E in whichA is Ser, Thr, Asn, Glu, Ile.B is Ser, Thr, Asp, Asn,C is Thr, Ser, Asn, Arg, Lys, Trp,D is Tyr, andE is Thr, Ser, Arg, Gly.And wherein all amino acids in the D peptide are the D stereoisomeric configuration and said peptide composition is administered in a therapeutically effective dose wherein said composition acts to suppress inflammation underlying the loss of brain function. The D peptide may be esterified, glycosylated, or amidated at E to enhance tissue distribution by promoting egress from the circulation and penetration into the brain.